Table 2.
Group comparison | Incidence, P | Severity, P | Mean days, P |
|
---|---|---|---|---|
Onset | Maximum duration | |||
DC w/Hsp60sp vs. control | <0.003 | <0.001 | <0.001 | <0.001 |
DC w/Hsp60sp vs. DC w/Qdm | <0.01 | <0.01 | <0.01 | <0.002 |
DC w/Hsp60sp vs. CD8−/DCw/Hsp60sp | <0.02 | <0.01 | <0.002 | <0.002 |